Renal cell carcinoma

Last reviewed: 26 Aug 2022
Last updated: 26 Jul 2022

Summary

Definition

History and exam

Key diagnostic factors

  • asymptomatic (incidental finding)
  • hematuria
  • flank pain
  • palpable abdominal mass
More key diagnostic factors

Other diagnostic factors

  • nonspecific systemic symptoms
  • signs of hepatic dysfunction
  • myoneuropathy
  • lower limb edema
  • scrotal varicocele
  • dermatologic manifestation (hereditary syndromes)
  • vision loss (von Hippel Lindau)
Other diagnostic factors

Risk factors

  • smoking
  • male sex
  • age over 55 years
  • residence in developed countries
  • black/American-Indian ethnicity
  • obesity
  • hypertension
  • positive family history of RCC
  • history of hereditary syndromes
  • history of acquired renal cystic disease
  • asbestos/cadmium
  • obstetric history/estrogen exposure
  • pelvic radiation
More risk factors

Diagnostic investigations

1st investigations to order

  • CBC
  • LDH
  • corrected calcium
  • liver function tests
  • coagulation profile
  • creatinine
  • estimated GFR
  • urinalysis
  • abdominal/pelvic ultrasound
  • CT abdomen/pelvis
  • MRI abdomen/pelvis
More 1st investigations to order

Investigations to consider

  • CT chest
  • MRI brain/spine
  • bone scan
  • biopsy
  • surgical pathology
More investigations to consider

Emerging tests

  • PET scan

Treatment algorithm

ONGOING

small renal mass or RCC stage 1 or 2

RCC stage 3

RCC stage 4 (metastatic disease)

Contributors

Authors

Rodrigo R. Pessoa, MD, PhD

Urology physician

Anshutz Medical Campus

University of Colorado

UCASOM Division of Urology

Denver

CO

Disclosures

RRP declares that he has no competing interests.

Simon Kim, MD, MPH

Associate Professor of Surgery

Associate Program Director

Anschutz Medical Campus

University of Colorado

UCSOM Division of Urology 

Denver

CO

Disclosures

SK declares that he has no competing interests.

Acknowledgements

Dr Rodrigo R. Pessoa and Dr Simon Kim would like to gratefully acknowledge Dr Amishi Y. Shah, Dr Sonal Gandhi, and Jennifer J. Knox, previous contributors to this topic.

Disclosures

AYS has an unpaid advisory role for Merck pharmaceuticals. SG and JJK declare that they have no competing interests.

Peer reviewers

Stephen A. Boorjian, MD

Assistant Professor

Fox Chase Cancer Center

Philadelphia

PA

Disclosures

SAB has been reimbursed by Pfizer for serving on its speakers bureau. SAB is co-author of a reference cited in this topic.

Thomas J. Guzzo, MD, MPH

Assistant Professor of Urology and Surgery

The Hospital of the University of Pennsylvania

Philadelphia

PA

Disclosures

TJG declares that he has no competing interests.

Jonathan Waxman, BSc, MBBS, MD, FRCP

Professor of Oncology

Imperial College

London

UK

Disclosures

JW declares that he has no competing interests.

  • Renal cell carcinoma images
  • Differentials

    • Benign renal cyst
    • Ureteric cancer
    • Bladder cancer
    More Differentials
  • Guidelines

    • NCCN clinical practice guidelines in oncology: kidney cancer
    • Management of advanced kidney cancer
    More Guidelines
  • Patient leaflets

    Kidney cancer

    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer